FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

27326511000001103: Cortaflex HA 200mg capsules (Equine America UK Ltd) 60 capsule (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 15-Oct 2014. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
83780901000001115 Cortaflex HA 200mg capsules (Equine America UK Ltd) 60 capsule (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
83781001000001112 Cortaflex HA 200mg capsules (Equine America UK Ltd) 60 capsule en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Cortaflex HA 200mg capsules (Equine America UK Ltd) 60 capsule Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Cortaflex HA 200mg capsules (Equine America UK Ltd) 60 capsule Discontinued indicator Discontinued AMPP(qualifier value) true Inferred relationship Existential restriction modifier
Cortaflex HA 200mg capsules (Equine America UK Ltd) 60 capsule VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Cortaflex HA 200mg capsules (Equine America UK Ltd) 60 capsule Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Cortaflex HA 200mg capsules (Equine America UK Ltd) 60 capsule Is a Generic Cortaflex HA 200mg capsules 60 capsule true Inferred relationship Existential restriction modifier
Cortaflex HA 200mg capsules (Equine America UK Ltd) 60 capsule Has AMP Cortaflex HA 200mg capsules (Equine America UK Ltd) true Inferred relationship Existential restriction modifier
Cortaflex HA 200mg capsules (Equine America UK Ltd) 60 capsule Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Cortaflex HA 200mg capsules (Equine America UK Ltd) 60 capsule VMP prescribing status (attribute) Never valid to prescribe as a VMP true Inferred relationship Existential restriction modifier
Cortaflex HA 200mg capsules (Equine America UK Ltd) 60 capsule VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Cortaflex HA 200mg capsules (Equine America UK Ltd) 60 capsule Has specific active ingredient Hyaluronic acid true Inferred relationship Existential restriction modifier
Cortaflex HA 200mg capsules (Equine America UK Ltd) 60 capsule Has specific active ingredient Chondroitin sulfate true Inferred relationship Existential restriction modifier
Cortaflex HA 200mg capsules (Equine America UK Ltd) 60 capsule Has specific active ingredient Glucosamine sulphate false Inferred relationship Existential restriction modifier
Cortaflex HA 200mg capsules (Equine America UK Ltd) 60 capsule Has dispensed dose form Capsule true Inferred relationship Existential restriction modifier
Cortaflex HA 200mg capsules (Equine America UK Ltd) 60 capsule Legal category Legal category not applicable true Inferred relationship Existential restriction modifier
Cortaflex HA 200mg capsules (Equine America UK Ltd) 60 capsule Discontinued indicator Never discontinued false Inferred relationship Existential restriction modifier
Cortaflex HA 200mg capsules (Equine America UK Ltd) 60 capsule Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Cortaflex HA 200mg capsules (Equine America UK Ltd) 60 capsule Has specific active ingredient Glucosamine sulfate true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start